sclareol oxide

14,15-di-nor-8,13-epoxylabd-12-ene

CAS: 5153-92-4 C18 H30 O MW: 262.43630000

Identification

Namesclareol oxide
IUPAC3,4a,7,7,10a-pentamethyl-1,5,6,6a,8,9,10,10b-octahydrobenzo[f]chromene
CAS Number5153-92-4
FDA UNIISearch
Molecular FormulaC18 H30 O
Molecular Weight262.43630000
Nikkaji NumberJ129.759G

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 325.00 to 326.00 °C. @ 760.00 mm Hg (est)
Vapor Pressure 0.000435 mmHg @ 25.00 °C. (est)
Flash Point 296.00 °F. TCC ( 146.80 °C. ) (est)
logP (o/w) 6.365 (est)
Soluble in alcohol
Insoluble in water

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorynatural substances and extractives
Recommendation for sclareol oxide usage levels up tonot for fragrance use.
Recommendation for sclareol oxide flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

None Found

Natural Occurrence

ballota nigra cistus twig/leaf oil @ 0.2% Data sage clary sage salvia limbata salvia sclarea oil @ 0.08% Data

Synonyms

14,15- di-nor-8,13-epoxylabd-12-ene 3,4a,7,7,10a- pentamethyl-1,5,6,6a,8,9,10,10b-octahydrobenzo[f]chromene sclareoloxide PubMed: Essential oil compositions of two populations of Salvia samuelssonii growing in different biogeographical regions of Jordan. PubMed: Diels-Alder cycloaddition approach to puupehenone-related metabolites: synthesis of the potent angiogenesis inhibitor 8-epipuupehedione. PubMed: Synthesis of ent-thallusin.